In this study, we found that TRPM8 inhibition could reduce the F4/80 positive cell population and inhibit the transcript levels of IL-6, IL-1β, TNFα, and MCP-1 in murine models of liver fibrosis. Here, CCL2 is linked to Hepatic fibrosis.